Besse, A.; Kraus, M.; Mendez-Lopez, M.; Maurits, E.; Overkleeft, H.S.; Driessen, C.; Besse, L.
Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors. Cells 2022, 11, 838.
https://doi.org/10.3390/cells11050838
AMA Style
Besse A, Kraus M, Mendez-Lopez M, Maurits E, Overkleeft HS, Driessen C, Besse L.
Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors. Cells. 2022; 11(5):838.
https://doi.org/10.3390/cells11050838
Chicago/Turabian Style
Besse, Andrej, Marianne Kraus, Max Mendez-Lopez, Elmer Maurits, Herman S. Overkleeft, Christoph Driessen, and Lenka Besse.
2022. "Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors" Cells 11, no. 5: 838.
https://doi.org/10.3390/cells11050838
APA Style
Besse, A., Kraus, M., Mendez-Lopez, M., Maurits, E., Overkleeft, H. S., Driessen, C., & Besse, L.
(2022). Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors. Cells, 11(5), 838.
https://doi.org/10.3390/cells11050838